Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Change in Accured Expenses (2016 - 2026)

Rockwell Medical filings provide 16 years of Change in Accured Expenses readings, the most recent being $625000.0 for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 320.85% to $625000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.7 million, a 62.38% decrease, with the full-year FY2025 number at -$1.7 million, down 62.38% from a year prior.
  • Change in Accured Expenses hit $625000.0 in Q4 2025 for Rockwell Medical, up from -$139000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $2.9 million in Q3 2023 to a low of -$3.3 million in Q1 2023.
  • Median Change in Accured Expenses over the past 5 years was $58000.0 (2022), compared with a mean of -$30150.0.
  • Biggest five-year swings in Change in Accured Expenses: skyrocketed 600.0% in 2021 and later tumbled 414.84% in 2023.
  • Rockwell Medical's Change in Accured Expenses stood at $777000.0 in 2021, then surged by 128.83% to $1.8 million in 2022, then crashed by 63.05% to $657000.0 in 2023, then tumbled by 143.07% to -$283000.0 in 2024, then surged by 320.85% to $625000.0 in 2025.
  • The last three reported values for Change in Accured Expenses were $625000.0 (Q4 2025), -$139000.0 (Q3 2025), and -$503000.0 (Q2 2025) per Business Quant data.